Literature DB >> 619937

Drug metabolism in epileptics: in vivo and in vitro correlations.

E A Sotaniemi, R O Pelkonen, J Ahokas, H I Pirttiaho, J Ahlqvist.   

Abstract

1. The effect of inducing drug therapy on the relationship between in vitro (cytochrome P-450 content) and in vivo (antipyrine kinetics) was investigated by comparing eleven consecutively treated epileptics with two groups of controls, eleven subjects with normal liver histology and eleven disease matched non-epileptics, all underwent diagnostice liver biopsy. 2. The epileptics had significantly higher cytochrom P-450 level in biopsies and they also metabolized antipyrine faster than the controls. 3. Decrease in antipyrine half-life in epileptics was related with alterations in liver histology, whereas the level of cytochrome P-450 was not. 4. There was a linear relationship between these two indices of enzyme induction when regressed on logarithmic data.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 619937      PMCID: PMC1429229          DOI: 10.1111/j.1365-2125.1978.tb01600.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  19 in total

1.  The fate of antipyrine in man.

Authors:  B B BRODIE; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1950-01       Impact factor: 4.030

2.  Histological changes in the liver and indices of drug metabolism in alcoholics.

Authors:  E A Sotaniemi; J Ahlqvist; R O Pelkonen; H Pirttiaho; P V Luoma
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

3.  Pharmacological implications of microsomal enzyme induction.

Authors:  A H Conney
Journal:  Pharmacol Rev       Date:  1967-09       Impact factor: 25.468

4.  Transverse mounting of ribbons on groups of slides for comparing different stains in adjacent sections.

Authors:  J Ahlqvist
Journal:  Stain Technol       Date:  1970-01

5.  Effect of diphenylhydantoin on hepatic drug hydroxylation.

Authors:  F Petruch; R V Schüppel; G Steinhilber
Journal:  Eur J Clin Pharmacol       Date:  1974-07-26       Impact factor: 2.953

6.  Drug metabolism and androgen control therapy in prostatic cancer.

Authors:  E A Sotaniemi; M J Kontturi; T K Larmi
Journal:  Clin Pharmacol Ther       Date:  1973 May-Jun       Impact factor: 6.875

Review 7.  Effects of liver disease on drug disposition in man.

Authors:  G R Wilkinson; S Schenker
Journal:  Biochem Pharmacol       Date:  1976-12-15       Impact factor: 5.858

8.  Interindividual differences in rates of drug oxidation in man.

Authors:  D S Davies; S S Thorgeirsson; A Breckenridge; M Orme
Journal:  Drug Metab Dispos       Date:  1973 Jan-Feb       Impact factor: 3.922

9.  Determination of drug metabolizing enzymes in needle biopsies of human liver.

Authors:  B Schoene; R A Fleischmann; H Remmer; H F von Oldershausen
Journal:  Eur J Clin Pharmacol       Date:  1972-03       Impact factor: 2.953

10.  Effect of antiepileptic drugs on the elimination of various tetracycline derivatives.

Authors:  P J Neuvonen; O Penttilä; R Lehtovaara; K Aho
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

View more
  13 in total

Review 1.  Pharmacokinetic drug interactions with phenytoin (Part II).

Authors:  R L Nation; A M Evans; R W Milne
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

2.  Induction of drug-metabolizing enzymes by tricyclic antidepressants in human liver: characterization and partial resolution of cytochromes P-450.

Authors:  T Cresteil; C Célier; P Kremers; J P Flinois; P Beaune; J P Leroux
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

3.  Plasma levels and clinical response with imipramine in a study comparing efficacy with mianserin and nomifensine.

Authors:  S A Montgomery; D Roy; S Wynne-Willson; C Robinson; D B Montgomery
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

4.  Liver size and indices of drug metabolism in epileptics.

Authors:  H I Pirttiaho; E A Sotaniemi; J T Ahokas; U Pitkänen
Journal:  Br J Clin Pharmacol       Date:  1978-09       Impact factor: 4.335

Review 5.  Drug interactions with phenytoin.

Authors:  E Perucca; A Richens
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

6.  Placental transfer and pharmacokinetics of primidone and its metabolites phenobarbital, PEMA and hydroxyphenobarbital in neonates and infants of epileptic mothers.

Authors:  H Nau; D Rating; I Häuser; E Jäger; S Koch; H Helge
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

7.  Plasma high-density lipoproteins and hepatic microsomal enzyme induction. Relation to histological changes in the liver.

Authors:  P V Luoma; E A Sotaniemi; R O Pelkonen; A Arranto; C Ehnholm
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 8.  Pharmacokinetic interactions with antiepileptic drugs.

Authors:  E Perucca
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

9.  Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol.

Authors:  H I Pirttiaho; E A Sotaniemi; R O Pelkonen; U Pitkänen; M Anttila; H Sundqvist
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

10.  Coumarin 7-hydroxylase activity in human liver microsomes. Properties of the enzyme and interspecies comparisons.

Authors:  O Pelkonen; E A Sotaniemi; J T Ahokas
Journal:  Br J Clin Pharmacol       Date:  1985-01       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.